CVS Health Co. (NYSE:CVS) Shares Sold by Money Concepts Capital Corp

Money Concepts Capital Corp reduced its stake in CVS Health Co. (NYSE:CVS) by 12.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,192 shares of the pharmacy operator’s stock after selling 848 shares during the period. Money Concepts Capital Corp’s holdings in CVS Health were worth $278,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CVS. AMF Tjanstepension AB increased its holdings in CVS Health by 124.1% in the 3rd quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after purchasing an additional 34,198 shares in the last quarter. Czech National Bank increased its holdings in CVS Health by 7.2% in the 3rd quarter. Czech National Bank now owns 256,430 shares of the pharmacy operator’s stock valued at $16,124,000 after purchasing an additional 17,206 shares in the last quarter. Brookstone Capital Management increased its holdings in CVS Health by 4.6% in the 3rd quarter. Brookstone Capital Management now owns 62,589 shares of the pharmacy operator’s stock valued at $3,936,000 after purchasing an additional 2,764 shares in the last quarter. CWM LLC increased its holdings in CVS Health by 14.1% in the 3rd quarter. CWM LLC now owns 76,241 shares of the pharmacy operator’s stock valued at $4,794,000 after purchasing an additional 9,435 shares in the last quarter. Finally, Hexagon Capital Partners LLC increased its holdings in CVS Health by 3.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator’s stock valued at $331,000 after purchasing an additional 178 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of analyst reports. Evercore ISI upped their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research report on Monday, January 27th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. Royal Bank of Canada decreased their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Finally, UBS Group upped their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $68.12.

CVS Health Stock Performance

Shares of NYSE CVS opened at $54.20 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm’s 50-day moving average price is $51.02 and its two-hundred day moving average price is $56.04. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The stock has a market capitalization of $68.21 billion, a P/E ratio of 13.76, a P/E/G ratio of 0.62 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter last year, the company posted $2.21 earnings per share. CVS Health’s revenue was up 6.3% on a year-over-year basis. As a group, sell-side analysts forecast that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.91%. CVS Health’s payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.